A Biotech Founder Makes the Moral Case for Gene-Editing Human Embryos
60-Word AI Digest
The practice of editing the genes of embryos remains highly controversial and risky, but Origin Genomics founder Cathy Tie argues its a “moral imperative” to address hereditary diseases.
Key Takeaways
- A Biotech Founder Makes the Moral Case for Gene-Editing Human Embryos
- The practice of editing the genes of embryos remains highly controversial and risky, but Origin Genomics founder Cathy Tie argues its a “moral imperative” to address hereditary diseases.
- Click full coverage link below for the complete official dispatch.
The practice of editing the genes of embryos remains highly controversial and risky, but Origin Genomics founder Cathy Tie argues its a “moral imperative” to address hereditary diseases.
Original Publisher Attribution
This summary was curated from Wired.